Literature DB >> 14970089

Age-related macular degeneration: armed against ARMD.

Erica Weir.   

Abstract

Mesh:

Year:  2004        PMID: 14970089      PMCID: PMC332708     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

Review 1.  Age-related macular degeneration.

Authors:  Justin L Gottlieb
Journal:  JAMA       Date:  2002-11-13       Impact factor: 56.272

Review 2.  Too much of a good thing? Toxic effects of vitamin and mineral supplements.

Authors:  Eric Wooltorton
Journal:  CMAJ       Date:  2003-07-08       Impact factor: 8.262

Review 3.  Important causes of visual impairment in the world today.

Authors:  Nathan G Congdon; David S Friedman; Thomas Lietman
Journal:  JAMA       Date:  2003-10-15       Impact factor: 56.272

4.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.

Authors: 
Journal:  Arch Ophthalmol       Date:  2001-10

5.  A prospective study of cigarette smoking and age-related macular degeneration in women.

Authors:  J M Seddon; W C Willett; F E Speizer; S E Hankinson
Journal:  JAMA       Date:  1996-10-09       Impact factor: 56.272

6.  Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11.

Authors:  Neil M Bressler; Susan B Bressler; Nathan G Congdon; Frederick L Ferris; David S Friedman; Ronald Klein; Anne S Lindblad; Roy C Milton; Johanna M Seddon
Journal:  Arch Ophthalmol       Date:  2003-11
  6 in total
  2 in total

1.  Genetics and ARMD.

Authors:  Ian M MacDonald; Matthew A Lines
Journal:  CMAJ       Date:  2004-05-11       Impact factor: 8.262

Review 2.  The Evolving Functions of Autophagy in Ocular Health: A Double-edged Sword.

Authors:  Peiwei Chai; Hongyan Ni; He Zhang; Xianqun Fan
Journal:  Int J Biol Sci       Date:  2016-10-25       Impact factor: 6.580

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.